PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555756
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555756
Powered Surgical Instrument Market size was valued at USD 2,102.32 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.
A powered surgical instrument is a device that uses an external power source, such as electricity, compressed air, or batteries, to assist in surgical procedures. Unlike manual instruments, which rely on the surgeon's physical force, powered instruments offer increased precision, control, and efficiency. Common examples include electric drills, saws, and staplers used in various types of surgeries. These instruments help reduce manual effort and improve the speed and accuracy of surgical tasks.
Powered Surgical Instrument Market- Market Dynamics
The global increase in surgical procedures
The global rise in surgical procedures is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. As healthcare systems enhance their capabilities and broaden access to surgical care, more individuals are opting for various types of surgeries, ranging from elective to complex interventions. This trend is further supported by the growing demand for minimally invasive techniques and improved surgical outcomes. For instance, in 2022, the International Society of Aesthetic Plastic Surgery (ISAPS) reported an 11.2% increase in the number of procedures performed by plastic surgeons, with aesthetic surgeries alone rising by 41.3% over the previous four years. This surge underscores the expanding need for advanced surgical instruments and technologies to accommodate the growing volume of surgical procedures worldwide.
Powered Surgical Instrument Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2024-2032)
Based on Power Source segmentation, Electric Accessories was predicted to show maximum market share in the year 2023
Based on Application segmentation, Orthopedic surgery was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Powered Surgical Instrument Market is segmented on the basis of Power Source, Product, Application, and Region.
The market is divided into three categories based on Power Source: Electric Accessories currently lead due to their widespread adoption and technological advancements. Electric instruments offer high precision, reliable performance, and the ability to provide consistent power and control during surgeries. They are commonly used in a variety of procedures, including orthopedic, neurosurgical, and cardiovascular surgeries.
The market is divided into three categories based on Application: Orthopedic surgery is the leading segment due to the extensive use of powered instruments in various orthopedic procedures, such as joint replacements, bone drilling, and cutting. Orthopedic surgeries often require high precision and robust performance, making powered instruments essential for tasks like osteotomies and the fixation of fractures.
Powered Surgical Instrument Market- Geographical Insights
In North America, the powered surgical instrument market is highly advanced and competitive, steered by significant technological innovation and robust healthcare infrastructure. The United States and Canada are major contributors, with leading companies like Medtronic, Stryker, and Johnson & Johnson dominating the market. The region's strong emphasis on minimally invasive surgeries, coupled with high healthcare spending and a well-established medical device industry, fosters market growth. Additionally, North America's favorable regulatory environment and high adoption rates of advanced surgical technologies further bolster the market. The increasing prevalence of chronic diseases and the demand for precision in surgical procedures also drive the market forward.
The competitive landscape of the powered surgical instrument market is characterized by rapid technological advancements and a diverse range of key players. Major companies such as Medtronic, Stryker, and Johnson & Johnson lead the market with innovative solutions that enhance surgical precision and efficiency. The market is also influenced by emerging players and startups focusing on advanced technologies like robotics and artificial intelligence. Competition is driven by factors including product innovation, regulatory approvals, and strategic partnerships. Also, the market is expanding due to the growing demand for minimally invasive surgeries and increasing healthcare expenditures globally.
In April 2024, Elucent Medical, known for its In-Site Spatial Intelligence (iSI) technology, has raised $42.5 million in Series C funding led by Vensana Capital and RC Capital, with support from existing investors. This funding will advance the development and commercialization of Elucent's EnVisio(R) and SmartClip(R) technologies, aimed at enhancing precision and outcomes in cancer surgery.
In April 2024, Proprio unveiled a strategic partnership with Biedermann to transform surgery with AI-driven guidance technology.
In Sept 2024, Galen received De Novo authorization from the US FDA for its ENT robotic system. The system boosts otolaryngologists' abilities with advanced functionalities, leading to better patient outcomes.